- Home
- PLX vs AISP Comparison
PLX vs AISP Comparison
Compare PLX & AISP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLX
- AISP
- Stock Information
- Founded
- PLX 1993
- AISP 2006
- Country
- PLX United States
- AISP United States
- Employees
- PLX N/A
- AISP N/A
- Industry
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- AISP Blank Checks
- Sector
- PLX Health Care
- AISP Finance
- Exchange
- PLX Nasdaq
- AISP Nasdaq
- Market Cap
- PLX 204.9M
- AISP 186.4M
- IPO Year
- PLX 1998
- AISP N/A
- Fundamental
- Price
- PLX $2.19
- AISP $4.29
- Analyst Decision
- PLX Strong Buy
- AISP Strong Buy
- Analyst Count
- PLX 1
- AISP 1
- Target Price
- PLX $15.00
- AISP $6.00
- AVG Volume (30 Days)
- PLX 934.1K
- AISP 1.0M
- Earning Date
- PLX 11-13-2025
- AISP 11-05-2025
- Dividend Yield
- PLX N/A
- AISP N/A
- EPS Growth
- PLX N/A
- AISP N/A
- EPS
- PLX 0.08
- AISP N/A
- Revenue
- PLX $61,948,000.00
- AISP $13,724,085.00
- Revenue This Year
- PLX $14.53
- AISP $34.52
- Revenue Next Year
- PLX $75.77
- AISP $59.54
- P/E Ratio
- PLX $28.28
- AISP N/A
- Revenue Growth
- PLX 62.79
- AISP N/A
- 52 Week Low
- PLX $1.16
- AISP $2.08
- 52 Week High
- PLX $3.10
- AISP $7.66
- Technical
- Relative Strength Index (RSI)
- PLX 46.99
- AISP 39.50
- Support Level
- PLX $2.25
- AISP $4.01
- Resistance Level
- PLX $2.40
- AISP $4.87
- Average True Range (ATR)
- PLX 0.14
- AISP 0.29
- MACD
- PLX -0.02
- AISP -0.09
- Stochastic Oscillator
- PLX 40.70
- AISP 30.29
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
About AISP Airship AI Holdings Inc.
Airship AI Holdings Inc is a robust AI-driven data management platform that solves complex data challenges for large institutions operating in dynamic and mission-critical environments with rapidly increasing volumes of data being ingested from a similarly rapidly growing number of data sources. Its primary offerings include Outpost AI, Acropolis, and Airship Command. Its offerings allow customers to manage their data across the full data lifecycle, when and where need it, using a secure permission-based architecture.